Back
|
Cell No. : Cell Name
HPS4874 : update : 2024/03/22 |
||||
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dilated cardiomyopathy (dilated phase hypertrophic cardiomyopathy). Genome-edited iPS cell line. | |||
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of dilated cardiomyopathy (dilated phase hypertrophic cardiomyopathy) patient using Sendai virus vectors encoding OCT3/4, SOX2, KLF4, c-MYC. | |||
| Terms and conditions | 1) The iPS cells created using the Sendai virus vector are now available must be observed when using SeV-iPS cells. 2) The BIOLOGICAL RESOURCE must be used for academic research purpose conducted by RECIPIENT who belongs to a not-for profit academic organization (i.e. a university or another institution of higher education or any non-profit scientific or educational organization, including government agencies). 3) The RECIPIENT agrees to use the BIOLOGICAL RESOURSE only for publication of research papers. 4) The RECIPIENT agrees to obtain the prior written approval of the distribution from the APPROVER. 5) Contact Us : RIKEN Cell Bank | |||
| Remarks | ||||
| Order Form | Order Form(C-0042.pdf) Approval Form(C-0057.pdf) MTA(C-0065.pdf) | |||
| Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp). | ||||
| Basic information | Expected time | Upon a request we will start preparation. Contact us: cellips.brc@riken.jp | ||
| Reference information | Reference | 1 | ||
| User's Publication | 0 | |||
Top
Top
| User's Publication |
Back
CELL BANK Website